Pancreatic Cancer: Daraxonrasib
Commons · Question 7440 · Tabled 8 Jun 2026 · Department of Health and Social Care · Official record
Answered 15 Jun 2026
Question
Asked by Jim Shannon
To ask the Secretary of State for Health and Social Care, when the drug Daraxonrasib will be available to pancreatic cancer patients on the NHS.
Answer
Answered by Preet Kaur Gill, 15 Jun 2026
Daraxonrasib is not currently licensed in the United Kingdom. Should the manufacturer submit an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a product licence, the MHRA has processes in place to review and assess its b...